IP Library Granted Patent US 8,940,501
Granted Patent B2
US 8,940,501 · App. 13/145,644 · Granted Jan 27, 2015

Methods for ligation and uses thereof

Inventors: Hidde L. Ploegh (Brookline, MA); John M. Antos (Everett, WA); Maximilian Wei-Lin Popp (Pittsford, NY); Carla Guimaraes (Boston, MA)
Assignee: Whitehead Institute for Biomedical Research
C12N9/48C12N9/80A01K2217/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,501
App. No.
13/145,644
Granted
Jan 27, 2015
Kind
B2
Abstract

The present invention relates to methods for ligation. The invention provides novel reagents and methods for ligating an acyl donor compound with an acyl acceptor compound. Provided acyl donor compounds comprise a transamidase recognition sequence that allows ligation with a nucleophilic acyl acceptor in the presence of transamidase. The invention further provides kits comprising acyl donor compounds and optionally comprising other reagents for ligation.

Claims (109)

1. A method of ligation comprising the step of contacting an acyl donor compound of formula:

wherein

the transamidase recognition sequence is LPXT, wherein the X of the recognition sequence is any natural or unnatural amino acid;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 6, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

2. The method of claim 1 , wherein X is —O—.

3. The method of claim 1 , wherein the recognition sequence is LPXT, wherein the X of the recognition sequence is D, E, A, N, Q, K, or R.

4. The method of claim 1 , wherein the transamidase is sortase A.

5. The method of ligation of claim 1 comprising the step of contacting an acyl donor compound of formula:

wherein

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

R 2 is a natural or unnatural amino acid side chain;

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 100, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

6. A method of ligation comprising the step of contacting an acyl donor compound of formula:

wherein

the transamidase recognition sequence is selected from LPXT, SPXT, LAXT, LSXT, NPXT, VPXT, IPXT, and YPXR wherein the X of the recognition sequence is a natural or unnatural amino acid;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 6, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

7. The method of claim 6 , wherein X is —O—.

8. The method of claim 6 , wherein the X of the recognition sequence is D, E, A, N, Q, K, or R.

9. The method of claim 6 , wherein the transamidase is sortase A.

10. The method of claim 6 , wherein the transamidase is sortase B.

11. The method of claim 6 comprising the step of contacting an acyl donor compound of formula:

wherein

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

R 2 is a natural or unnatural amino acid side chain;

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 100, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

12. A method of ligation comprising the step of contacting an acyl donor compound of formula:

wherein

the transamidase recognition sequence is selected from: LPKT (SEQ ID NO: 69), LPIT (SEQ ID NO: 70), LPDT (SEQ ID NO: 71), SPKT (SEQ ID NO: 72), LAET (SEQ ID NO: 73), LAAT (SEQ ID NO: 74), LAET (SEQ ID NO: 75), LAST (SEQ ID NO: 76), LAET (SEQ ID NO: 77), LPLT (SEQ ID NO: 78), LSRT (SEQ ID NO: 79), LPET (SEQ ID NO: 53), VPDT (SEQ ID NO: 80), IPQT (SEQ ID NO: 81), YPRR (SEQ ID NO: 82), LPMT (SEQ ID NO: 83), LPLT (SEQ ID NO: 84), LAFT (SEQ ID NO: 85), LPQT (SEQ ID NO: 86), NSKT (SEQ ID NO: 87), NPQT (SEQ ID NO: 88), NAKT (SEQ ID NO: 89), and NPQS (SEQ ID NO: 90);

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 6, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

13. The method of claim 12 , wherein X is —O—.

14. The method of claim 12 , wherein the transamidase is sortase A.

15. The method of claim 12 , wherein the transamidase is sortase B.

16. The method of claim 12 comprising the step of contacting an acyl donor compound of formula:

wherein

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

R 2 is a natural or unnatural amino acid side chain;

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 100, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

17. A method of ligation comprising the step of contacting an acyl donor compound of formula:

wherein

the transamidase recognition sequence is X 1 PX 2 X 3 , where X 1 is leucine, isoleucine, valine or methionine; X 2 is any amino acid; X 3 is threonine, serine or alanine; P is proline;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 6, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

18. The method of claim 17 , wherein X is —O—.

19. The method of claim 17 , wherein the transamidase is sortase A.

20. The method of claim 17 , wherein the transamidase is sortase B.

21. The method of claim 17 comprising the step of contacting an acyl donor compound of formula:

wherein

A 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label;

X is —O— or —S—;

R is hydrogen, substituted or unsubstituted aliphatic, or substituted or unsubstituted heteroaliphatic;

R 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

R 2 is a natural or unnatural amino acid side chain;

with a nucleophilic compound of formula:

wherein

B 1 is acyl, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, a peptide, a protein, a polynucleotide, a carbohydrate, a tag, a metal atom, a contrast agent, a catalyst, a non-polypeptide polymer, a recognition element, a small molecule, a lipid, or a label; and

n is an integer from 0 to 100, inclusive;

in the presence of a transamidase enzyme under suitable conditions to form a compound of formula:

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 27, 2018
From: WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046443/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2011
From: PLOEGH, HIDDE L.; ANTOS, JOHN M.; POPP, MAXIMILIAN WEI-LIN; GUIMARAES, CARLA
To: WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 026872/0528 →
Continuity (2)
Provisional Application 61148787 · Jan 30, 2009
Related Publication 20110321183A1 · Dec 29, 2011